UA117255U - METHOD OF DIAGNOSIS OF INFECTED PANCREATONECROSE, BY DETERMINATION OF THE CONTENT OF ANTIMicrobial peptides - Google Patents

METHOD OF DIAGNOSIS OF INFECTED PANCREATONECROSE, BY DETERMINATION OF THE CONTENT OF ANTIMicrobial peptides

Info

Publication number
UA117255U
UA117255U UAU201612838U UAU201612838U UA117255U UA 117255 U UA117255 U UA 117255U UA U201612838 U UAU201612838 U UA U201612838U UA U201612838 U UAU201612838 U UA U201612838U UA 117255 U UA117255 U UA 117255U
Authority
UA
Ukraine
Prior art keywords
infected
content
antimicrobial peptides
pancreatonecrose
diagnosis
Prior art date
Application number
UAU201612838U
Other languages
Ukrainian (uk)
Inventor
Ігор Миколайович Вовчук
Віталій Анатолійович Кацал
Original Assignee
Вінницький Національний Медичний Університет Ім. М.І. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вінницький Національний Медичний Університет Ім. М.І. Пирогова filed Critical Вінницький Національний Медичний Університет Ім. М.І. Пирогова
Priority to UAU201612838U priority Critical patent/UA117255U/en
Publication of UA117255U publication Critical patent/UA117255U/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Спосіб діагностики інфікованого панкреатонекрозу включає визначення вмісту протимікробних пептидів. Набирають плазму крові та визначають в сироватці крові хворого вміст каталецидину LL-37 методом імуноферментного аналізу, діапазон вимірювання: 0,14-100 нг/мл, чутливість: 0,14 нг/мл. При достовірному зниженні даного показника 10,73±0,043 нг/мл діагностують інфікований панкреатонекроз.A method for diagnosing infected pancreatonecrosis involves determining the content of antimicrobial peptides. Blood plasma was collected and the serum content of catalecidin LL-37 was determined by enzyme-linked immunosorbent assay, measuring range 0.14-100 ng / ml, sensitivity 0.14 ng / ml. With a significant decrease in this indicator 10,73 ± 0,043 ng / ml diagnose infected pancreatonecrosis.

UAU201612838U 2016-12-16 2016-12-16 METHOD OF DIAGNOSIS OF INFECTED PANCREATONECROSE, BY DETERMINATION OF THE CONTENT OF ANTIMicrobial peptides UA117255U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201612838U UA117255U (en) 2016-12-16 2016-12-16 METHOD OF DIAGNOSIS OF INFECTED PANCREATONECROSE, BY DETERMINATION OF THE CONTENT OF ANTIMicrobial peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201612838U UA117255U (en) 2016-12-16 2016-12-16 METHOD OF DIAGNOSIS OF INFECTED PANCREATONECROSE, BY DETERMINATION OF THE CONTENT OF ANTIMicrobial peptides

Publications (1)

Publication Number Publication Date
UA117255U true UA117255U (en) 2017-06-26

Family

ID=59092870

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201612838U UA117255U (en) 2016-12-16 2016-12-16 METHOD OF DIAGNOSIS OF INFECTED PANCREATONECROSE, BY DETERMINATION OF THE CONTENT OF ANTIMicrobial peptides

Country Status (1)

Country Link
UA (1) UA117255U (en)

Similar Documents

Publication Publication Date Title
MX2020009021A (en) Assays for detecting the presence or amount of an anti-drug antibody.
BR112015021199A2 (en) method for determining whether an infection is bacterial and / or viral, lateral flow device for detecting an analyte in a sample, and device for detecting a bacterial and / or viral marker in a sample
BR112017004899A2 (en) misfolded protein detection
BR112014013082A2 (en) method for detecting nucleosome adducts
WO2015157704A3 (en) Methods and compositions for detecting misfolded proteins
IN2014DE01077A (en)
RU2016137685A (en) DIAGNOSTIC METHOD OF TUBERCULOSIS
BR112018010764A2 (en) method for detecting bacterial activity in a biological sample and corresponding detection unit
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
BR112014031958A2 (en) bag3 as tissue marker and biochemical serum
ES2845150T3 (en) Diagnosis of acute pancreatitis (AP) by detecting glycoprotein 2 alpha isoform (GP2A)
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
WO2013167727A3 (en) Method for determining arthritis relapse risk
WO2011109112A3 (en) Method of detecting tau protein and tau fragments in serum
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
MX2021003484A (en) Methods for detecting hook effect(s) associated with anaylte(s) of interest during or resulting from the conductance of diagnostic assay(s).
BR112017005243A2 (en) "detection of dysfunction with biological considerations"
BR112015032574A8 (en) transient signal error interception for an analyte measurement determined from a specified sampling time derived from a detected physical characteristic of the sample containing the analyte
UA117255U (en) METHOD OF DIAGNOSIS OF INFECTED PANCREATONECROSE, BY DETERMINATION OF THE CONTENT OF ANTIMicrobial peptides
SG10201907690TA (en) Device and method for detecting target molecules
BR112017004810A2 (en) immunoassay
WO2014159920A4 (en) A device and method for the detection and diagnosis of aggressive and metastatic cancer and cancer stem cells employing podocalyxin and tra biomarkers
RU2014113841A (en) METHOD FOR EARLY DIAGNOSTICS OF ENDOGENOUS INTOXICATION
BR112017005246A2 (en) dysfunction detection
PH12020550119A1 (en) Method for reducing measurement error in latex agglutination immunoassay